Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Baker Hughes CoBHGE · Entity 2993 | Chief Global Ops Officer | July 31, 2017 | August 02, 2017 |
| Ecovyst Inc.ECVT · Entity 4897 | Director · See Remarks | March 01, 2022 | March 03, 2022 |
| Helmerich & Payne, Inc.HP · Entity 482 | Director | March 05, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Baker Hughes Co
Report date July 31, 2017 · Filed August 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 71,157 |
Reported balance
After 2017-07-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-07-31 · Grant · Acquired 71,157 · Balance 71,157 F1: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.89 · Expires 2027-07-31 | Direct | 70,507 |
Reported balance
After 2017-07-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-07-31 · Grant · Acquired 70,507 · Balance 70,507 F3: The stock option vests in three equal annual installments beginning one year from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer.
F2: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant.
F3: The stock option vests in three equal annual installments beginning one year from the date of grant.
Ecovyst Inc.
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,236,453 |
Reported balance
After 2022-03-01 transaction · row 1
1 source rowRow 1 · 2022-03-01 · Grant · Acquired 142,765 · Balance 1,236,453 |
Helmerich & Payne, Inc.
Report date March 05, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,056 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Grant · Acquired 5,273 · Balance 67,056 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Baker Hughes Holdings LLC
Report date July 03, 2017 · Filed July 03, 2017
Section 16 reporting ended · disclosed 2017-07-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1.00 Par ValueSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-07-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2013-11-12 · Sale · Disposed 6,200 · Balance 95,453.3293 F1: Sale prices for these transactions ranged from $57.14 to $57.77. Row 2 · 2013-11-13 · Sale · Disposed 13,800 · Balance 81,653.3293 F1: Sale prices for these transactions ranged from $57.14 to $57.77. Row 3 · 2017-06-19 · Grant · Acquired 104.4452 · Balance 81,757.7745 F2: Acquisition under Employee Stock Purchase Plan exempt from Section 16b of the Securities Exchange Act of 1934 by Rule 16b-3. Row 4 · 2017-07-03 · Disposition to issuer · Disposed 81,757.7745 · Balance 0 F3: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.28 · Expires 2020-01-19 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-07-03 · Disposition to issuer · Disposed 12,000 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.17 · Expires 2020-07-21 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-07-03 · Disposition to issuer · Disposed 11,600 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.32 · Expires 2021-01-26 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-07-03 · Disposition to issuer · Disposed 9,300 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.00 · Expires 2021-07-19 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-07-03 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.44 · Expires 2022-01-25 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-07-03 · Disposition to issuer · Disposed 22,619 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.30 · Expires 2022-07-16 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-07-03 · Disposition to issuer · Disposed 18,208 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.21 · Expires 2023-01-24 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-07-03 · Disposition to issuer · Disposed 25,875 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.75 · Expires 2023-07-24 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-07-03 · Disposition to issuer · Disposed 24,508 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.73 · Expires 2024-01-22 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-07-03 · Disposition to issuer · Disposed 23,914 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.70 · Expires 2024-07-14 | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-07-03 · Disposition to issuer · Disposed 18,670 · Balance 0 F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-07-03 · Disposition to issuer · Disposed 17,341 · Balance 0 F5: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2017-07-03 · Disposition to issuer · Disposed 49,684 · Balance 0 F5: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2017-07-03 · Disposition to issuer · Disposed 44,120 · Balance 0 F5: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-07-03 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2017-07-03 · Disposition to issuer · Disposed 26,138 · Balance 0 F5: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). |
Filing footnotes · ownership attribution and instrument terms
F1: Sale prices for these transactions ranged from $57.14 to $57.77.
F2: Acquisition under Employee Stock Purchase Plan exempt from Section 16b of the Securities Exchange Act of 1934 by Rule 16b-3.
F3: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend").
F4: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date.
F5: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 6, 2026 21:06 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 5,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001463291-26-000002 · form4-03062026_090317.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,056 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 21:06 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 7,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007374 · form4-03072025_090324.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,783 Read SEC document |
| February 10, 2025 Filed Feb 11, 2025 21:41 UTC | Helmerich & Payne, Inc. HP · Entity 482 | PurchaseCommon Stock | 37,356 | $27.08 | $1,011,600.48 |
DisclosureSEC source: 0001415889-25-003578 · form4-02112025_090228.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,606 F1 · price: The price in this column is the weighted average sale price for the transactions reported. The prices ranged from $26.63 to $27.52. The reporting person will provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold by the reporting person at each separate price. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:09 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 4,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006074 · form4-03012024_090357.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,250 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:23 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 4,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004121 · form4-03032023_090347.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,575 Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:05 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 4,733 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002535 · form4-03042022_040307.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,378 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 16:31 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock | 142,765 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009082 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,236,453 Read SEC document |
| January 17, 2022 Filed Jan 19, 2022 16:28 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock | 194,363 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002417 · doc4.xml · nonDerivative · entry 2 Chariag Belgacem · CIK 0001463291 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093,688 Read SEC document |
| January 17, 2022 Filed Jan 19, 2022 16:28 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock | 291,546 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002417 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899,325 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:20 UTC | Helmerich & Payne, Inc. HP · Entity 482 | GrantCommon Stock | 3,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007954 · edgar.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,645 Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 20:09 UTC | Ecovyst Inc. PQG · Entity 4897 | Tax withholdingCommon Stock | 10,465 | $15.50 | $162,155.18 |
DisclosureSEC source: 0000899243-21-003029 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,779 Read SEC document |
| January 18, 2021 Filed Jan 20, 2021 20:42 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 324,887 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-002583 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618,244 Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 21:12 UTC | Ecovyst Inc. PQG · Entity 4897 | Tax withholdingCommon Stock | 7,272 | $14.11 | $102,586.10 |
DisclosureSEC source: 0000899243-21-001025 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,357 Read SEC document |
| August 09, 2020 Filed Aug 11, 2020 19:11 UTC | Ecovyst Inc. PQG · Entity 4897 | Tax withholdingCommon Stock | 12,200 | $12.23 | $149,145.00 |
DisclosureSEC source: 0000899243-20-022028 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,629 Read SEC document |
| March 19, 2020 Filed Mar 20, 2020 07:01 UTC | Ecovyst Inc. PQG · Entity 4897 | PurchaseCommon Stock | 11,926 | $10.22 | $121,914.73 |
DisclosureSEC source: 0000899243-20-009059 · doc4.xml · nonDerivative · entry 2 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,829 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.72 to $10.58, inclusive. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 07:01 UTC | Ecovyst Inc. PQG · Entity 4897 | PurchaseCommon Stock | 41,574 | $9.31 | $387,078.88 |
DisclosureSEC source: 0000899243-20-009059 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,903 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.98 to $9.52, inclusive. The reporting person undertakes to provide to PQ Group Holdings Inc., any security holder of PQ Group Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| January 20, 2020 Filed Jan 22, 2020 20:49 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 120,084 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-001730 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,329 Read SEC document |
| January 05, 2020 Filed Jan 7, 2020 19:26 UTC | Ecovyst Inc. PQG · Entity 4897 | Tax withholdingCommon Stock | 9,642 | $16.61 | $160,105.41 |
DisclosureSEC source: 0000899243-20-000783 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · CEO, President & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,245 Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 18:12 UTC | Ecovyst Inc. PQG · Entity 4897 | Tax withholdingCommon Stock | 12,200 | $14.15 | $172,630.00 |
DisclosureSEC source: 0000899243-19-021662 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · CEO, President & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,887 Read SEC document |
| March 11, 2019 Filed Mar 13, 2019 17:13 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 85,658 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-007548 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · CEO, President & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,087 Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 18:36 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantStock Option (right to buy) · Derivative | 241,316 | $0.00 Strike: $17.50 | $0.00 |
DisclosureSEC source: 0000899243-18-022164 · doc4.xml · derivative · entry 2 Chariag Belgacem · CIK 0001463291 · Director · CEO, President & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,316 Underlying: Common Stock · 241,316 shares Expires 2028-08-09 F1 · derivative.exercise_date: This option vests in two equal annual installments beginning on August 9, 2019. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 18:36 UTC | Ecovyst Inc. PQG · Entity 4897 | GrantCommon Stock | 75,429 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-022164 · doc4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Director · CEO, President & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,429 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 15:36 UTC | Baker Hughes Co BHGE · Entity 2993 | GrantStock Option (Right to Buy) · Derivative | 70,507 | $0.00 Strike: $36.89 | $0.00 |
DisclosureSEC source: 0001701605-17-000070 · wf-form4_150170257508109.xml · derivative · entry 2 Chariag Belgacem · CIK 0001463291 · Chief Global Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,507 Underlying: Class A Common Stock · 70,507 shares Expires 2027-07-31 F3 · derivative.exercise_date: The stock option vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 15:36 UTC | Baker Hughes Co BHGE · Entity 2993 | GrantRestricted Stock Unit · Derivative | 71,157 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001701605-17-000070 · wf-form4_150170257508109.xml · derivative · entry 1 Chariag Belgacem · CIK 0001463291 · Chief Global Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,157 Underlying: Class A Common Stock · 71,157 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 26,138 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 18 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 26,138 shares Expires not disclosed F5 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 44,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 17 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 44,120 shares Expires not disclosed F5 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 49,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 16 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 49,684 shares Expires not disclosed F5 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerRestricted Stock Units · Derivative | 17,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 15 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 17,341 shares Expires not disclosed F5 · derivative.exercise_price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · price: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.exercise_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). F5 · derivative.expiration_date: Prior to the Closing Date, each restricted stock unit represented a contingent right to one share of BHI Common Stock (each, a "BHI RSU"). Pursuant to the Transaction Agreement, on the Closing Date, each outstanding BHI RSU was cancelled and converted into a restricted stock unit with respect to a share of BHGE Common Stock, with the same terms and conditions as applied to such BHI RSU immediately prior to the Closing Date (including the right with respect to the Special Dividend). Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 18,670 | Not disclosed Strike: $72.70 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 14 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 18,670 shares Expires 2024-07-14 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 23,914 | Not disclosed Strike: $56.73 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 13 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 23,914 shares Expires 2024-01-22 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 24,508 | Not disclosed Strike: $47.75 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 12 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 24,508 shares Expires 2023-07-24 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 25,875 | Not disclosed Strike: $45.21 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 11 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 25,875 shares Expires 2023-01-24 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 18,208 | Not disclosed Strike: $39.30 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 10 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 18,208 shares Expires 2022-07-16 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 22,619 | Not disclosed Strike: $47.44 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 9 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 22,619 shares Expires 2022-01-25 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 7,500 | Not disclosed Strike: $77.00 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 8 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 7,500 shares Expires 2021-07-19 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 9,300 | Not disclosed Strike: $62.32 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 7 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 9,300 shares Expires 2021-01-26 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 11,600 | Not disclosed Strike: $49.17 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 6 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 11,600 shares Expires 2020-07-21 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerStock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $47.28 | Not disclosed |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · derivative · entry 5 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 12,000 shares Expires 2020-01-19 F4 · price: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. F4 · derivative.exercise_date: Pursuant to the Transaction Agreement, on the Closing Date, each outstanding option to purchase shares of BHI Common Stock (each, a "BHI Option"), whether or not exercisable, was cancelled and converted into a fully exercisable option to purchase an equal number of shares of BHGE Common Stock, with a per share exercise price equal to the per share exercise price of such BHI Option less $17.50 to reflect the Special Dividend, and otherwise with the same terms and conditions as applied to such BHI Option immediately prior to the Closing Date. Read SEC document |
| July 03, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Disposition to issuerCommon Stock, $1.00 Par Value | 81,757.7745 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · nonDerivative · entry 4 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend"). F3 · price: On the closing date (the "Closing Date") of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 30, 2016, among General Electric Company, a New York corporation, Baker Hughes Incorporated, a Delaware corporation ("BHI"), the Issuer and certain subsidiaries of BHI, as amended by that certain Amendment to Transaction Agreement and Plan of Merger dated as of March 27, 2017 (the "Transaction Agreement"), each outstanding share of common stock of the Issuer ("BHI Common Stock"), whether restricted or unrestricted, was cancelled and converted into the right to receive (a) one share of Class A common stock of Baker Hughes, a GE Company ("BHGE Common Stock") and (b) a special one-time cash dividend of $17.50 per share of BHGE Common Stock (the "Special Dividend"). Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 17:58 UTC | Baker Hughes Co BHGE · Entity 2993 | Tax withholdingClass A Common Stock | 48,725 | $37.25 | $1,815,006.25 |
DisclosureSEC source: 0001701605-17-000057 · wf-form4_149937826873991.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Chief Global Ops Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,177.7745 F1 · shares: Represents shares of Class A Common Stock of the Issuer withheld to satisfy tax withholding obligations arising on settlement of restricted stock units. Read SEC document |
| June 19, 2017 Filed Jul 3, 2017 19:39 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | GrantCommon Stock, $1.00 Par Value | 104.4452 | $47.87 | $5,000.00 |
DisclosureSEC source: 0001127602-17-022532 · form4.xml · nonDerivative · entry 3 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,757.7745 F2 · kind: Acquisition under Employee Stock Purchase Plan exempt from Section 16b of the Securities Exchange Act of 1934 by Rule 16b-3. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:11 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Tax withholdingCommon Stock, $1.00 Par Value | 5,326 | $60.28 | $321,051.28 |
DisclosureSEC source: 0001127602-17-010037 · form4.xml · nonDerivative · entry 2 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,653.3293 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 20:11 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | GrantCommon Stock, $1.00 Par Value | 12,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010037 · form4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,979.3293 F1 · shares: Represents shares earned for the performance share units granted in 2014 for the three-year performance period ending December 31, 2016 as approved by the Compensation Committee of the Board of Directors on March 1, 2017. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:27 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Exercise / conversionRestricted Stock Units · Derivative | 24,841 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-003046 · form4.xml · derivative · entry 3 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,684 Underlying: Common Stock, $1.00 Par Value · 24,841 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:27 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Tax withholdingCommon Stock, $1.00 Par Value | 10,421 | $63.10 | $657,565.10 |
DisclosureSEC source: 0001127602-17-003046 · form4.xml · nonDerivative · entry 2 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,285.3293 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 19:27 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Exercise / conversionCommon Stock, $1.00 Par Value | 24,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003046 · form4.xml · nonDerivative · entry 1 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,706.3293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 22:29 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | GrantRestricted Stock Units · Derivative | 26,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-002707 · form4.xml · derivative · entry 1 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,138 Underlying: Common Stock, $1.00 Par Value · 26,138 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F1 · price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 22:45 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Exercise / conversionRestricted Stock Units · Derivative | 4,823 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-002357 · form4.xml · derivative · entry 7 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $1.00 Par Value · 4,823 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F2 · price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 22:45 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Exercise / conversionRestricted Stock Units · Derivative | 17,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-002357 · form4.xml · derivative · entry 6 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,341 Underlying: Common Stock, $1.00 Par Value · 17,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F2 · price: Each restricted stock unit represents a right to receive without payment one share of Baker Hughes common stock. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning one year from the date of grant. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 22:45 UTC | Baker Hughes Holdings LLC BHI · Entity 50098 | Tax withholdingCommon Stock, $1.00 Par Value | 2,024 | $61.98 | $125,447.52 |
DisclosureSEC source: 0001127602-17-002357 · form4.xml · nonDerivative · entry 5 Chariag Belgacem · CIK 0001463291 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,865.329 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.